Nanologicas årsredovisning 2022
Pdf: Årsredovisning 2022 Nanologica AB (publ) ESEF zip: nanologicaabpubl-2022-12-31-sv ESEF preview
Pdf: Årsredovisning 2022 Nanologica AB (publ) ESEF zip: nanologicaabpubl-2022-12-31-sv ESEF preview
Nanologica AB’s Interim Report Jan-Sep 2022 The auditor’s report Q3 2022 (Swedish) Report presentation Q3 2022 FINANCIAL SUMMARY Net sales for the third quarter amounted to TSEK 401 (2,119) and for the nine-month period to TSEK 881 (12,238) The operating result for the quarter amounted to TSEK -9,610 (-11,718) and for the nine-month period to TSEK -37,599 (-26,581) Result after tax for the quarter amounted to TSEK -10,988 (-12,546) and for the nine-month period
The number of shares and votes in Nanologica AB (publ) has changed during the month of October as a result of the completion of the previously communicated preferential rights issue. As previously communicated, Nanologica’s board of directors on August 23, 2022, decided on a new share issue of approximately MSEK 94 with preferential rights for existing shareholders, in order to finance intensified investments in preparative chromatography. On October 10, Nanologica announced that the rights issue

Katarina Alenäs, SVP Chromatography Nanologica AB Who is Katarina Alenäs? I have a M.Sc. in Chemical Engineering and a B.Sc. in Pharmaceutical Sciences and have spent most of my professional career within chromatography which is an area very close to my heart. Before joining Nanologica, I was the Country General Manager at Agilent Technologies Sweden, and before that I have been Product Manager Shimadzu HPLC/LCMS and I started my career as a Development Engineer of